Financials

  • Market Capitalization 288.04 M
  • Employee 450
  • Founded 2014
  • CEO N/A
  • Website www.treace.com
  • Headquarter Florida, United States
  • FIGI BBG00GQKR6M4
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.63
Price to sales ratio
0.73

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3316
MASS
908 Devices Inc. - Common Stock
8.16 USD+2.64%+3.16%-5.45%+24.20%308.56 M USD
3361
CARL
Carlsmed, Inc. - Common Stock
10.80 USD-10.82%-12.55%-2.53%-28.00%293.60 M USD
3406
SGHT
Sight Sciences, Inc. - Common Stock
5.05 USD-5.43%-5.61%-0.20%+45.11%274.77 M USD
3451
PROF
Profound Medical Corp. - common stock
7.10 USD-0.70%-2.34%+4.87%+29.80%258.00 M USD

Frequently asked questions about Treace Medical Concepts, Inc. - Common Stock

What is the Treace Medical Concepts, Inc. - Common Stock stock price today?

The current price of Treace Medical Concepts, Inc. - Common Stock (TMCI) is 4.44. Over the past 24 hours, the stock has changed by -3.06%. Follow the TMCI chart for real-time price dynamics.

What is the stock ticker of Treace Medical Concepts, Inc. - Common Stock?

Treace Medical Concepts, Inc. - Common Stock trades under the ticker TMCI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Treace Medical Concepts, Inc. - Common Stock stock going up?

TMCI has changed by +2.30% over the last week, +13.55% over the last month, and -23.18% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Treace Medical Concepts, Inc. - Common Stock net income for the last quarter?

Treace Medical Concepts, Inc. - Common Stock reported net income of -17.96 M for the last quarter. The previous quarter showed -9.39 M, which means net income changed by -91.20%.

How many employees does Treace Medical Concepts, Inc. - Common Stock have?

As of the latest available data, Treace Medical Concepts, Inc. - Common Stock has 450 employees. Workforce size can provide additional context about the company's scale and operations.

What is Treace Medical Concepts, Inc. - Common Stock EBITDA?

Treace Medical Concepts, Inc. - Common Stock EBITDA is -16.27 M, and its EBITDA margin is -34.47%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Treace Medical Concepts, Inc. - Common Stock stock?

You can buy Treace Medical Concepts, Inc. - Common Stock (TMCI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Treace Medical Concepts, Inc. - Common Stock stock?

Investing in Treace Medical Concepts, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TMCI chart and related analysis on metatrader.com as part of your research.

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

News